Drug Design Development and Therapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-08-04 ms9000000076911288 来自浙江省

邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？

61 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-08-14 ms8000001566471502 来自山东省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：纳米载体;中药药理
经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右
16 April 2023 Submission created
19 April 2023 Submission submitted + Editorial checks
1 May 2023 Editorial checks completed moved to Compliance checks
5 May 2023 Peer review selection
17 May 2023 Peer review invitations sent
31 May 2023 First peer reviewer allocated
1 June 2023 Two or more peer reviewers allocated
1 June 2023 First report returned
14 June 2023 Second or more peer reviewer reports returned
15 June 2023 Report sent to the Editor-in-Chief
17 June 2023 Report: revise with changes
29 June 2023 Resubmission pending
19 July 2023 Resubmitted manuscript received
27 July 2023 Processing revised manuscript
4 August 2023 Sent to Editor-in-Chief for acceptance or rejection
4 August 2023 Peer reviewer(s) second round
12 August 2023 Peer reviewer(s) second round completed
12 August 2023 Invoice to follow for article processing charge subject to final decision
14 August 2023 Accepted for publication, invoice sent

68 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-11-17 ms6000001755760996 来自吉林省

我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-09-20 41982559 来自广东省

偏重的研究方向：药理
经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-03-30 ms8000001566471502 来自江苏省

偏重的研究方向：中药
经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊

62 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-03-20 ms5000000946930121 来自北京

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：药理
经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。
从1A到4B差不多2个月。

66 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-08-09 ms8000001566471502 来自山东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：中药药理
经验分享：请问大家4CR会持续多久啊，最近很紧张

59 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-05-05 ms7000001766502651 来自辽宁省

生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？

74 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-04-23 17848b826bm 来自山东省

一直是2E状态，焦急

65 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151252, encodeId=147f215125205, content=邮件已经确认付费，状态依然是1DA - WAITING FOR THIRD PARTY BILLING INFORMATION，请问需要什么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efde6513305, createdName=ms9000000076911288, createdTime=Fri Aug 04 11:48:25 CST 2023, time=2023-08-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152655, encodeId=b2002152655d4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：纳米载体;中药药理 经验分享：今天接收啦，发个时间给大家看一下，总共4个月左右 16 April 2023 Submission created 19 April 2023 Submission submitted + Editorial checks 1 May 2023 Editorial checks completed moved to Compliance checks 5 May 2023 Peer review selection 17 May 2023 Peer review invitations sent 31 May 2023 First peer reviewer allocated 1 June 2023 Two or more peer reviewers allocated 1 June 2023 First report returned 14 June 2023 Second or more peer reviewer reports returned 15 June 2023 Report sent to the Editor-in-Chief 17 June 2023 Report: revise with changes 29 June 2023 Resubmission pending 19 July 2023 Resubmitted manuscript received 27 July 2023 Processing revised manuscript 4 August 2023 Sent to Editor-in-Chief for acceptance or rejection 4 August 2023 Peer reviewer(s) second round 12 August 2023 Peer reviewer(s) second round completed 12 August 2023 Invoice to follow for article processing charge subject to final decision 14 August 2023 Accepted for publication, invoice sent, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Mon Aug 14 10:18:50 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169183, encodeId=81632169183a3, content=我想知道2A最久可以持续多久，我已经持续17天了，还在邀请审稿人，捉急毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2696410801, createdName=ms6000001755760996, createdTime=Fri Nov 17 21:33:55 CST 2023, time=2023-11-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理 经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122743, encodeId=2cbc2122e4320, content=偏重的研究方向：中药 经验分享：请问大家，原始数据需要上传吗，免疫荧光的数据应该怎么传啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Thu Mar 30 14:34:39 CST 2023, time=2023-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2120562, encodeId=3d18212056273, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：1月投稿。目前返回修订稿了。4B状态。期望好消息。 从1A到4B差不多2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f78282923, createdName=ms5000000946930121, createdTime=Mon Mar 20 14:33:40 CST 2023, time=2023-03-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151950, encodeId=cc0b215195059, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药药理 经验分享：请问大家4CR会持续多久啊，最近很紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b31d6477968, createdName=ms8000001566471502, createdTime=Wed Aug 09 14:46:34 CST 2023, time=2023-08-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2130160, encodeId=6b9d2130160e0, content=生信部分用了TCGA数据，需要提供伦理证明，各位大神遇到过这种情况吗？怎么解决的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88ad5479178, createdName=ms7000001766502651, createdTime=Fri May 05 05:15:20 CST 2023, time=2023-05-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2127845, encodeId=fc99212e845e4, content=一直是2E状态，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eojibdGMygibUsKdN526iajHeVGsSCYXVClya7hiaXyPpnJPe2DXrkcVzJVhUwyS17l0ickQVzKakkhNvA/132, createdBy=494d5324966, createdName=17848b826bm, createdTime=Sun Apr 23 16:59:41 CST 2023, time=2023-04-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1196386, encodeId=f6b71196386c4, content=2a已经5天了，大家知道这个杂志一般多少天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 23 12:41:38 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-02-23 审稿人爸爸求求您

2a已经5天了，大家知道这个杂志一般多少天吗

101 24

展开24条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务